Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-08-21
1983-02-01
Ford, John M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424199, 548112, 546 22, A61K 31675, A61K 31685, C07F 958, C07F 965
Patent
active
043715265
ABSTRACT:
Compounds of the formula ##STR1## are disclosed. These compounds are useful as hypotensive agents due to their angiotensin converting enzyme inhibition activity.
REFERENCES:
patent: 4105776 (1978-08-01), Ondetti et al.
patent: 4151172 (1979-04-01), Ondetti et al.
patent: 4168267 (1979-09-01), Petrillo
patent: 4211786 (1980-07-01), Rovnyak
patent: 4254267 (1981-03-01), Rovnyak
patent: 4266065 (1981-05-01), Rovnyak
Davis Stephen B.
E. R. Squibb & Sons Inc.
Ford John M.
Harkaway Natalia
Levinson Lawrence S.
LandOfFree
Phosphinylalkanoyl substituted 4,5-dihydropyrazole-5-carboxylic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphinylalkanoyl substituted 4,5-dihydropyrazole-5-carboxylic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphinylalkanoyl substituted 4,5-dihydropyrazole-5-carboxylic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2407378